MARUCCI, M. A.; LECHNER , D. W.; TAFUTO , B. A. Safety outcomes of low versus high dose imatinib mesylate in patients with advanced, metastatic, or nonresectable gastrointestinal stromal tumors: A systematic review. Gastrointestinal Tract, [S. l.], v. 2, n. 1, 2024. DOI: 10.54844/git.2023.482. Disponível em: https://www.hksmp.com/journals/git/article/view/482. Acesso em: 17 may. 2024.